Skip to content

Clinical trials

Phase 2 Cholangiocarcinoma trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Phase: Phase 2 Status: Unknown status Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20091
20101
20111
20121
20141
20171
20183
20193
20208
20211
20226
20236
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status35

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Zhongshan Hospital5
Tianjin Medical University Cancer Institute and Hospital3
Sun Yat-sen University2
Asan Medical Center1
Austin Health1
Benaroya Research Institute1
Binkui Li1
Central Texas Veterans Health Care System1
Convalife (Shanghai) Co., Ltd.1
Eastern Hepatobiliary Surgery Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma35
Gallbladder Neoplasms4
Biliary Tract Neoplasms3
Carcinoma2
Carcinoma, Hepatocellular2
Carcinoma, Non-Small-Cell Lung2
Colorectal Neoplasms2
Neoplasm Metastasis2
Pancreatic Neoplasms2
Salivary Gland Neoplasms2

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.